Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H28ClN3O5S |
Molecular Weight | 445.961 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(=O)(=O)NCCN1CCC(CCC(=O)C2=CC(Cl)=C(N)C3=C2OCCO3)CC1
InChI
InChIKey=NBUGBCTWXCXBQD-UHFFFAOYSA-N
InChI=1S/C19H28ClN3O5S/c1-29(25,26)22-6-9-23-7-4-13(5-8-23)2-3-16(24)14-12-15(20)17(21)19-18(14)27-10-11-28-19/h12-13,22H,2-11,21H2,1H3
Molecular Formula | C19H28ClN3O5S |
Molecular Weight | 445.961 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Sulamserod is a methanesulfonamide derivative patented by British multinational pharmaceutical company GlaxoSmithKline as 5-HT4 receptor antagonist, with antiarrhythmic activities for the treatment of the certain cardiovascular condition. 5-HT4 receptor blockade could have antiarrhythmic effects by decreasing intracellular Ca2+ concentration and delayed rectifier potassium current and prolonging atrial refractory period. In preclinical models, Sulamserod prolongs mean atrial effective refractory period and wavelength, reduces the dispersion of effective refractory period, and minimally slows conduction velocity in pigs.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10556228
pig 30 mg/kg
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:31:49 GMT 2023
by
admin
on
Fri Dec 15 16:31:49 GMT 2023
|
Record UNII |
73EBX462X5
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66885
Created by
admin on Fri Dec 15 16:31:49 GMT 2023 , Edited by admin on Fri Dec 15 16:31:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
219757-90-1
Created by
admin on Fri Dec 15 16:31:49 GMT 2023 , Edited by admin on Fri Dec 15 16:31:49 GMT 2023
|
PRIMARY | |||
|
DTXSID70176382
Created by
admin on Fri Dec 15 16:31:49 GMT 2023 , Edited by admin on Fri Dec 15 16:31:49 GMT 2023
|
PRIMARY | |||
|
9805252
Created by
admin on Fri Dec 15 16:31:49 GMT 2023 , Edited by admin on Fri Dec 15 16:31:49 GMT 2023
|
PRIMARY | |||
|
73EBX462X5
Created by
admin on Fri Dec 15 16:31:49 GMT 2023 , Edited by admin on Fri Dec 15 16:31:49 GMT 2023
|
PRIMARY | |||
|
7910
Created by
admin on Fri Dec 15 16:31:49 GMT 2023 , Edited by admin on Fri Dec 15 16:31:49 GMT 2023
|
PRIMARY | |||
|
300000034442
Created by
admin on Fri Dec 15 16:31:49 GMT 2023 , Edited by admin on Fri Dec 15 16:31:49 GMT 2023
|
PRIMARY | |||
|
CHEMBL303182
Created by
admin on Fri Dec 15 16:31:49 GMT 2023 , Edited by admin on Fri Dec 15 16:31:49 GMT 2023
|
PRIMARY | |||
|
C152448
Created by
admin on Fri Dec 15 16:31:49 GMT 2023 , Edited by admin on Fri Dec 15 16:31:49 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|